Global Viral Detection Supply, Demand and Key Producers, 2026-2032
The global Viral Detection market size is expected to reach $ 2484 million by 2032, rising at a market growth of 14.9% CAGR during the forecast period (2026-2032).
Viral Detection refers to viral safety testing services performed for biologics, vaccines, recombinant proteins, monoclonal antibodies, cell therapies, gene therapies, as well as their raw materials, cell banks, virus seed stocks, unprocessed bulk harvests, and final product lots. It is not a single physical device; rather, it is an integrated quality-control service package composed of testing strategies, standard operating procedures, sample receipt and preparation workflows, indicator cell lines, nucleic-acid amplification systems, sequencing platforms, electron microscopy platforms, reference controls, data-analysis pipelines, and compliant reporting. Its major categories include cell-based in vitro assays, molecular methods such as PCR, qPCR, and ddPCR, broad-range NGS screening, TEM-based morphological identification, and dedicated assays for replication-competent AAV, replication-competent lentivirus, retroviruses, and related viral risks. The technical principle is to identify known or unknown viral contaminants in different sample matrices through viral growth effects, characteristic nucleic-acid sequences, particle morphology, host-range response, and orthogonal confirmation, then determine whether exogenous viral introduction or amplification risks exist in the manufacturing process. This service is mainly provided by CROs, contract testing laboratories, CDMOs with in-house quality platforms, and specialized biologics safety testing organizations. Its key technical requirements focus on sensitivity, specificity, coverage breadth, sample compatibility, contamination control, regulatory compliance, and robust GMP/GLP system execution. Typical use scenarios include cell bank release, raw material release, in-process control, unprocessed bulk testing, final lot release, and contamination investigation.
The expansion of the Viral Detection market is primarily driven by the continued growth of biologics, cell therapies, gene therapies, and novel vaccines. As product complexity rises, a single analytical method is no longer sufficient to cover all viral-risk scenarios, which is accelerating the combined use of cell-based assays, molecular methods, NGS, and electron microscopy. At the same time, updated regulatory frameworks such as ICH Q5A(R2) are bringing risk-based strategies, sample-tiering logic, animal-free alternatives, and faster release concepts to the forefront, pushing Viral Detection from a ?pre-submission compliance task? toward a continuous quality system spanning cell banking, raw materials, process control, lot release, and deviation investigation. For downstream users, building an internal high-grade viral safety platform requires heavy capital, long validation timelines, and difficult maintenance; therefore, outsourcing to specialized organizations with GMP/GLP systems, established methods, and regulatory communication experience has become a practical route to improve efficiency, shorten timelines, and reduce compliance risk.
The main market challenge is no longer whether testing is required, but how to balance accuracy, coverage, speed, cost, and regulatory acceptance. Traditional in vitro and in vivo assays provide broad coverage, but their timelines are longer and sample compatibility can be limited. PCR-based methods are fast and sensitive, but they do not fully address unknown viral threats. NGS is growing rapidly, yet it places higher demands on data interpretation, background-noise control, contamination tracing, method validation, and cross-batch consistency. In cell and gene therapy, complex sample matrices, vector-related signals, and specialized replication-competent virus risks further increase the difficulty of method development and orthogonal confirmation. The industry also faces practical constraints such as cross-region regulatory differences, scheduling bottlenecks, limited expert capacity, and high biosafety requirements. Future competition will therefore center not only on the number of tests offered, but also on platform strength, regulatory alignment, turnaround time, and investigation capability.
Downstream demand is shifting from isolated testing items toward lifecycle-wide testing portfolios. Historically, demand was concentrated on foundational release testing for cell banks and raw materials. Now, more programs are moving Viral Detection upstream into vector construction, donor-material screening, process monitoring, and contamination root-cause tracing, while also extending it downstream into commercial-stage ongoing quality surveillance. Monoclonal antibodies, recombinant proteins, and vaccines remain the most stable demand base, whereas cell therapies, viral vectors, RNA therapeutics, and complex bioprocesses represent the most elastic sources of incremental demand. Supplier selection is also evolving: customers are looking beyond price and increasingly prioritizing integrated capabilities that combine risk assessment, method development, GMP testing, deviation investigation, and global filing support. This will continue to push the market toward platformization, globalization, and higher-value services.
This report studies the global Viral Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Detection total market, 2021-2032, (USD Million)
Global Viral Detection total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Viral Detection total market, key domestic companies, and share, (USD Million)
Global Viral Detection revenue by player, revenue and market share 2021-2026, (USD Million)
Global Viral Detection total market by Type, CAGR, 2021-2032, (USD Million)
Global Viral Detection total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Viral Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Charles River Laboratories, Eurofins, SGS, Sartorius, Asahi Kasei, Samsung Biologics, Syngene, Intertek, Minaris Advanced Therapies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Viral Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Viral Detection Market, By Region:
1. How big is the global Viral Detection market?
2. What is the demand of the global Viral Detection market?
3. What is the year over year growth of the global Viral Detection market?
4. What is the total value of the global Viral Detection market?
5. Who are the Major Players in the global Viral Detection market?
6. What are the growth factors driving the market demand?
Viral Detection refers to viral safety testing services performed for biologics, vaccines, recombinant proteins, monoclonal antibodies, cell therapies, gene therapies, as well as their raw materials, cell banks, virus seed stocks, unprocessed bulk harvests, and final product lots. It is not a single physical device; rather, it is an integrated quality-control service package composed of testing strategies, standard operating procedures, sample receipt and preparation workflows, indicator cell lines, nucleic-acid amplification systems, sequencing platforms, electron microscopy platforms, reference controls, data-analysis pipelines, and compliant reporting. Its major categories include cell-based in vitro assays, molecular methods such as PCR, qPCR, and ddPCR, broad-range NGS screening, TEM-based morphological identification, and dedicated assays for replication-competent AAV, replication-competent lentivirus, retroviruses, and related viral risks. The technical principle is to identify known or unknown viral contaminants in different sample matrices through viral growth effects, characteristic nucleic-acid sequences, particle morphology, host-range response, and orthogonal confirmation, then determine whether exogenous viral introduction or amplification risks exist in the manufacturing process. This service is mainly provided by CROs, contract testing laboratories, CDMOs with in-house quality platforms, and specialized biologics safety testing organizations. Its key technical requirements focus on sensitivity, specificity, coverage breadth, sample compatibility, contamination control, regulatory compliance, and robust GMP/GLP system execution. Typical use scenarios include cell bank release, raw material release, in-process control, unprocessed bulk testing, final lot release, and contamination investigation.
The expansion of the Viral Detection market is primarily driven by the continued growth of biologics, cell therapies, gene therapies, and novel vaccines. As product complexity rises, a single analytical method is no longer sufficient to cover all viral-risk scenarios, which is accelerating the combined use of cell-based assays, molecular methods, NGS, and electron microscopy. At the same time, updated regulatory frameworks such as ICH Q5A(R2) are bringing risk-based strategies, sample-tiering logic, animal-free alternatives, and faster release concepts to the forefront, pushing Viral Detection from a ?pre-submission compliance task? toward a continuous quality system spanning cell banking, raw materials, process control, lot release, and deviation investigation. For downstream users, building an internal high-grade viral safety platform requires heavy capital, long validation timelines, and difficult maintenance; therefore, outsourcing to specialized organizations with GMP/GLP systems, established methods, and regulatory communication experience has become a practical route to improve efficiency, shorten timelines, and reduce compliance risk.
The main market challenge is no longer whether testing is required, but how to balance accuracy, coverage, speed, cost, and regulatory acceptance. Traditional in vitro and in vivo assays provide broad coverage, but their timelines are longer and sample compatibility can be limited. PCR-based methods are fast and sensitive, but they do not fully address unknown viral threats. NGS is growing rapidly, yet it places higher demands on data interpretation, background-noise control, contamination tracing, method validation, and cross-batch consistency. In cell and gene therapy, complex sample matrices, vector-related signals, and specialized replication-competent virus risks further increase the difficulty of method development and orthogonal confirmation. The industry also faces practical constraints such as cross-region regulatory differences, scheduling bottlenecks, limited expert capacity, and high biosafety requirements. Future competition will therefore center not only on the number of tests offered, but also on platform strength, regulatory alignment, turnaround time, and investigation capability.
Downstream demand is shifting from isolated testing items toward lifecycle-wide testing portfolios. Historically, demand was concentrated on foundational release testing for cell banks and raw materials. Now, more programs are moving Viral Detection upstream into vector construction, donor-material screening, process monitoring, and contamination root-cause tracing, while also extending it downstream into commercial-stage ongoing quality surveillance. Monoclonal antibodies, recombinant proteins, and vaccines remain the most stable demand base, whereas cell therapies, viral vectors, RNA therapeutics, and complex bioprocesses represent the most elastic sources of incremental demand. Supplier selection is also evolving: customers are looking beyond price and increasingly prioritizing integrated capabilities that combine risk assessment, method development, GMP testing, deviation investigation, and global filing support. This will continue to push the market toward platformization, globalization, and higher-value services.
This report studies the global Viral Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Detection total market, 2021-2032, (USD Million)
Global Viral Detection total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Viral Detection total market, key domestic companies, and share, (USD Million)
Global Viral Detection revenue by player, revenue and market share 2021-2026, (USD Million)
Global Viral Detection total market by Type, CAGR, 2021-2032, (USD Million)
Global Viral Detection total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Viral Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Charles River Laboratories, Eurofins, SGS, Sartorius, Asahi Kasei, Samsung Biologics, Syngene, Intertek, Minaris Advanced Therapies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Viral Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Viral Detection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Plaque Assays
- PCR
- ELISA
- Others
- Standard Testing Services
- Customized Method Development Services
- Validation Services
- Batch Release Testing Services
- Investigation Services
- Others
- Raw Materials
- Cell Banks
- Viral Seed Stocks / Viral Vectors
- In-Process Samples
- Bulk Harvest / Drug Substance
- Final Product
- Others
- Research Use Only
- Non-GLP / Non-GMP Testing
- GLP-compliant Testing
- GMP-compliant Testing
- Regulatory Submission Support Testing
- Others
- Blood & Blood Products
- Cellular & Gene Therapy Products
- Stem Cell Products
- Tissue & Tissue Products
- Vaccines and Therapeutics
- Merck KGaA
- Charles River Laboratories
- Eurofins
- SGS
- Sartorius
- Asahi Kasei
- Samsung Biologics
- Syngene
- Intertek
- Minaris Advanced Therapies
- Texcell
- PathoQuest
- Clean Cells
- Avance Biosciences
- Microbiologics
- Alcami
- Creative Biolabs
- Creative Biogene
- WuXi AppTec
- WuXi Biologics
1. How big is the global Viral Detection market?
2. What is the demand of the global Viral Detection market?
3. What is the year over year growth of the global Viral Detection market?
4. What is the total value of the global Viral Detection market?
5. Who are the Major Players in the global Viral Detection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Viral Detection Introduction
1.2 World Viral Detection Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Viral Detection Total Market by Region (by Headquarter Location)
1.3.1 World Viral Detection Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Viral Detection Revenue (2021-2032)
1.3.3 China Based Company Viral Detection Revenue (2021-2032)
1.3.4 Europe Based Company Viral Detection Revenue (2021-2032)
1.3.5 Japan Based Company Viral Detection Revenue (2021-2032)
1.3.6 South Korea Based Company Viral Detection Revenue (2021-2032)
1.3.7 ASEAN Based Company Viral Detection Revenue (2021-2032)
1.3.8 India Based Company Viral Detection Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Viral Detection Consumption Value (2021-2032)
2.2 World Viral Detection Consumption Value by Region
2.2.1 World Viral Detection Consumption Value by Region (2021-2026)
2.2.2 World Viral Detection Consumption Value Forecast by Region (2027-2032)
2.3 United States Viral Detection Consumption Value (2021-2032)
2.4 China Viral Detection Consumption Value (2021-2032)
2.5 Europe Viral Detection Consumption Value (2021-2032)
2.6 Japan Viral Detection Consumption Value (2021-2032)
2.7 South Korea Viral Detection Consumption Value (2021-2032)
2.8 ASEAN Viral Detection Consumption Value (2021-2032)
2.9 India Viral Detection Consumption Value (2021-2032)
3 WORLD VIRAL DETECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Viral Detection Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Viral Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Viral Detection in 2025
3.2.3 Global Concentration Ratios (CR8) for Viral Detection in 2025
3.3 Viral Detection Company Evaluation Quadrant
3.4 Viral Detection Market: Overall Company Footprint Analysis
3.4.1 Viral Detection Market: Region Footprint
3.4.2 Viral Detection Market: Company Product Type Footprint
3.4.3 Viral Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Viral Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Viral Detection Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Viral Detection Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Viral Detection Consumption Value Comparison
4.2.1 United States VS China: Viral Detection Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Viral Detection Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Viral Detection Companies and Market Share, 2021-2026
4.3.1 United States Based Viral Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Viral Detection Revenue, (2021-2026)
4.4 China Based Companies Viral Detection Revenue and Market Share, 2021-2026
4.4.1 China Based Viral Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Viral Detection Revenue, (2021-2026)
4.5 Rest of World Based Viral Detection Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Viral Detection Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Viral Detection Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Detection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Plaque Assays
5.2.2 PCR
5.2.3 ELISA
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Viral Detection Market Size by Type (2021-2026)
5.3.2 World Viral Detection Market Size by Type (2027-2032)
5.3.3 World Viral Detection Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SERVICE DELIVERY FORMAT
6.1 World Viral Detection Market Size Overview by Service Delivery Format: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Service Delivery Format
6.2.1 Standard Testing Services
6.2.2 Customized Method Development Services
6.2.3 Validation Services
6.2.4 Batch Release Testing Services
6.2.5 Investigation Services
6.2.6 Others
6.3 Market Segment by Service Delivery Format
6.3.1 World Viral Detection Market Size by Service Delivery Format (2021-2026)
6.3.2 World Viral Detection Market Size by Service Delivery Format (2027-2032)
6.3.3 World Viral Detection Market Size Market Share by Service Delivery Format (2027-2032)
7 MARKET ANALYSIS BY SAMPLE MATRIX
7.1 World Viral Detection Market Size Overview by Sample Matrix: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sample Matrix
7.2.1 Raw Materials
7.2.2 Cell Banks
7.2.3 Viral Seed Stocks / Viral Vectors
7.2.4 In-Process Samples
7.2.5 Bulk Harvest / Drug Substance
7.2.6 Final Product
7.2.7 Others
7.3 Market Segment by Sample Matrix
7.3.1 World Viral Detection Market Size by Sample Matrix (2021-2026)
7.3.2 World Viral Detection Market Size by Sample Matrix (2027-2032)
7.3.3 World Viral Detection Market Size Market Share by Sample Matrix (2027-2032)
8 MARKET ANALYSIS BY COMPLIANCE LEVEL
8.1 World Viral Detection Market Size Overview by Compliance Level: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Compliance Level
8.2.1 Research Use Only
8.2.2 Non-GLP / Non-GMP Testing
8.2.3 GLP-compliant Testing
8.2.4 GMP-compliant Testing
8.2.5 Regulatory Submission Support Testing
8.2.6 Others
8.3 Market Segment by Compliance Level
8.3.1 World Viral Detection Market Size by Compliance Level (2021-2026)
8.3.2 World Viral Detection Market Size by Compliance Level (2027-2032)
8.3.3 World Viral Detection Market Size Market Share by Compliance Level (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Viral Detection Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Blood & Blood Products
9.2.2 Cellular & Gene Therapy Products
9.2.3 Stem Cell Products
9.2.4 Tissue & Tissue Products
9.2.5 Vaccines and Therapeutics
9.3 Market Segment by Application
9.3.1 World Viral Detection Market Size by Application (2021-2026)
9.3.2 World Viral Detection Market Size by Application (2027-2032)
9.3.3 World Viral Detection Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Merck KGaA
10.1.1 Merck KGaA Details
10.1.2 Merck KGaA Major Business
10.1.3 Merck KGaA Viral Detection Product and Services
10.1.4 Merck KGaA Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Merck KGaA Recent Developments/Updates
10.1.6 Merck KGaA Competitive Strengths & Weaknesses
10.2 Charles River Laboratories
10.2.1 Charles River Laboratories Details
10.2.2 Charles River Laboratories Major Business
10.2.3 Charles River Laboratories Viral Detection Product and Services
10.2.4 Charles River Laboratories Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Charles River Laboratories Recent Developments/Updates
10.2.6 Charles River Laboratories Competitive Strengths & Weaknesses
10.3 Eurofins
10.3.1 Eurofins Details
10.3.2 Eurofins Major Business
10.3.3 Eurofins Viral Detection Product and Services
10.3.4 Eurofins Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Eurofins Recent Developments/Updates
10.3.6 Eurofins Competitive Strengths & Weaknesses
10.4 SGS
10.4.1 SGS Details
10.4.2 SGS Major Business
10.4.3 SGS Viral Detection Product and Services
10.4.4 SGS Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 SGS Recent Developments/Updates
10.4.6 SGS Competitive Strengths & Weaknesses
10.5 Sartorius
10.5.1 Sartorius Details
10.5.2 Sartorius Major Business
10.5.3 Sartorius Viral Detection Product and Services
10.5.4 Sartorius Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Sartorius Recent Developments/Updates
10.5.6 Sartorius Competitive Strengths & Weaknesses
10.6 Asahi Kasei
10.6.1 Asahi Kasei Details
10.6.2 Asahi Kasei Major Business
10.6.3 Asahi Kasei Viral Detection Product and Services
10.6.4 Asahi Kasei Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Asahi Kasei Recent Developments/Updates
10.6.6 Asahi Kasei Competitive Strengths & Weaknesses
10.7 Samsung Biologics
10.7.1 Samsung Biologics Details
10.7.2 Samsung Biologics Major Business
10.7.3 Samsung Biologics Viral Detection Product and Services
10.7.4 Samsung Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Samsung Biologics Recent Developments/Updates
10.7.6 Samsung Biologics Competitive Strengths & Weaknesses
10.8 Syngene
10.8.1 Syngene Details
10.8.2 Syngene Major Business
10.8.3 Syngene Viral Detection Product and Services
10.8.4 Syngene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Syngene Recent Developments/Updates
10.8.6 Syngene Competitive Strengths & Weaknesses
10.9 Intertek
10.9.1 Intertek Details
10.9.2 Intertek Major Business
10.9.3 Intertek Viral Detection Product and Services
10.9.4 Intertek Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Intertek Recent Developments/Updates
10.9.6 Intertek Competitive Strengths & Weaknesses
10.10 Minaris Advanced Therapies
10.10.1 Minaris Advanced Therapies Details
10.10.2 Minaris Advanced Therapies Major Business
10.10.3 Minaris Advanced Therapies Viral Detection Product and Services
10.10.4 Minaris Advanced Therapies Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Minaris Advanced Therapies Recent Developments/Updates
10.10.6 Minaris Advanced Therapies Competitive Strengths & Weaknesses
10.11 Texcell
10.11.1 Texcell Details
10.11.2 Texcell Major Business
10.11.3 Texcell Viral Detection Product and Services
10.11.4 Texcell Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 Texcell Recent Developments/Updates
10.11.6 Texcell Competitive Strengths & Weaknesses
10.12 PathoQuest
10.12.1 PathoQuest Details
10.12.2 PathoQuest Major Business
10.12.3 PathoQuest Viral Detection Product and Services
10.12.4 PathoQuest Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 PathoQuest Recent Developments/Updates
10.12.6 PathoQuest Competitive Strengths & Weaknesses
10.13 Clean Cells
10.13.1 Clean Cells Details
10.13.2 Clean Cells Major Business
10.13.3 Clean Cells Viral Detection Product and Services
10.13.4 Clean Cells Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.13.5 Clean Cells Recent Developments/Updates
10.13.6 Clean Cells Competitive Strengths & Weaknesses
10.14 Avance Biosciences
10.14.1 Avance Biosciences Details
10.14.2 Avance Biosciences Major Business
10.14.3 Avance Biosciences Viral Detection Product and Services
10.14.4 Avance Biosciences Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.14.5 Avance Biosciences Recent Developments/Updates
10.14.6 Avance Biosciences Competitive Strengths & Weaknesses
10.15 Microbiologics
10.15.1 Microbiologics Details
10.15.2 Microbiologics Major Business
10.15.3 Microbiologics Viral Detection Product and Services
10.15.4 Microbiologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.15.5 Microbiologics Recent Developments/Updates
10.15.6 Microbiologics Competitive Strengths & Weaknesses
10.16 Alcami
10.16.1 Alcami Details
10.16.2 Alcami Major Business
10.16.3 Alcami Viral Detection Product and Services
10.16.4 Alcami Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.16.5 Alcami Recent Developments/Updates
10.16.6 Alcami Competitive Strengths & Weaknesses
10.17 Creative Biolabs
10.17.1 Creative Biolabs Details
10.17.2 Creative Biolabs Major Business
10.17.3 Creative Biolabs Viral Detection Product and Services
10.17.4 Creative Biolabs Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.17.5 Creative Biolabs Recent Developments/Updates
10.17.6 Creative Biolabs Competitive Strengths & Weaknesses
10.18 Creative Biogene
10.18.1 Creative Biogene Details
10.18.2 Creative Biogene Major Business
10.18.3 Creative Biogene Viral Detection Product and Services
10.18.4 Creative Biogene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.18.5 Creative Biogene Recent Developments/Updates
10.18.6 Creative Biogene Competitive Strengths & Weaknesses
10.19 WuXi AppTec
10.19.1 WuXi AppTec Details
10.19.2 WuXi AppTec Major Business
10.19.3 WuXi AppTec Viral Detection Product and Services
10.19.4 WuXi AppTec Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.19.5 WuXi AppTec Recent Developments/Updates
10.19.6 WuXi AppTec Competitive Strengths & Weaknesses
10.20 WuXi Biologics
10.20.1 WuXi Biologics Details
10.20.2 WuXi Biologics Major Business
10.20.3 WuXi Biologics Viral Detection Product and Services
10.20.4 WuXi Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.20.5 WuXi Biologics Recent Developments/Updates
10.20.6 WuXi Biologics Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Viral Detection Industry Chain
11.2 Viral Detection Upstream Analysis
11.3 Viral Detection Midstream Analysis
11.4 Viral Detection Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Viral Detection Introduction
1.2 World Viral Detection Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Viral Detection Total Market by Region (by Headquarter Location)
1.3.1 World Viral Detection Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Viral Detection Revenue (2021-2032)
1.3.3 China Based Company Viral Detection Revenue (2021-2032)
1.3.4 Europe Based Company Viral Detection Revenue (2021-2032)
1.3.5 Japan Based Company Viral Detection Revenue (2021-2032)
1.3.6 South Korea Based Company Viral Detection Revenue (2021-2032)
1.3.7 ASEAN Based Company Viral Detection Revenue (2021-2032)
1.3.8 India Based Company Viral Detection Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Viral Detection Consumption Value (2021-2032)
2.2 World Viral Detection Consumption Value by Region
2.2.1 World Viral Detection Consumption Value by Region (2021-2026)
2.2.2 World Viral Detection Consumption Value Forecast by Region (2027-2032)
2.3 United States Viral Detection Consumption Value (2021-2032)
2.4 China Viral Detection Consumption Value (2021-2032)
2.5 Europe Viral Detection Consumption Value (2021-2032)
2.6 Japan Viral Detection Consumption Value (2021-2032)
2.7 South Korea Viral Detection Consumption Value (2021-2032)
2.8 ASEAN Viral Detection Consumption Value (2021-2032)
2.9 India Viral Detection Consumption Value (2021-2032)
3 WORLD VIRAL DETECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Viral Detection Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Viral Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Viral Detection in 2025
3.2.3 Global Concentration Ratios (CR8) for Viral Detection in 2025
3.3 Viral Detection Company Evaluation Quadrant
3.4 Viral Detection Market: Overall Company Footprint Analysis
3.4.1 Viral Detection Market: Region Footprint
3.4.2 Viral Detection Market: Company Product Type Footprint
3.4.3 Viral Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Viral Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Viral Detection Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Viral Detection Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Viral Detection Consumption Value Comparison
4.2.1 United States VS China: Viral Detection Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Viral Detection Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Viral Detection Companies and Market Share, 2021-2026
4.3.1 United States Based Viral Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Viral Detection Revenue, (2021-2026)
4.4 China Based Companies Viral Detection Revenue and Market Share, 2021-2026
4.4.1 China Based Viral Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Viral Detection Revenue, (2021-2026)
4.5 Rest of World Based Viral Detection Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Viral Detection Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Viral Detection Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Detection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Plaque Assays
5.2.2 PCR
5.2.3 ELISA
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Viral Detection Market Size by Type (2021-2026)
5.3.2 World Viral Detection Market Size by Type (2027-2032)
5.3.3 World Viral Detection Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SERVICE DELIVERY FORMAT
6.1 World Viral Detection Market Size Overview by Service Delivery Format: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Service Delivery Format
6.2.1 Standard Testing Services
6.2.2 Customized Method Development Services
6.2.3 Validation Services
6.2.4 Batch Release Testing Services
6.2.5 Investigation Services
6.2.6 Others
6.3 Market Segment by Service Delivery Format
6.3.1 World Viral Detection Market Size by Service Delivery Format (2021-2026)
6.3.2 World Viral Detection Market Size by Service Delivery Format (2027-2032)
6.3.3 World Viral Detection Market Size Market Share by Service Delivery Format (2027-2032)
7 MARKET ANALYSIS BY SAMPLE MATRIX
7.1 World Viral Detection Market Size Overview by Sample Matrix: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sample Matrix
7.2.1 Raw Materials
7.2.2 Cell Banks
7.2.3 Viral Seed Stocks / Viral Vectors
7.2.4 In-Process Samples
7.2.5 Bulk Harvest / Drug Substance
7.2.6 Final Product
7.2.7 Others
7.3 Market Segment by Sample Matrix
7.3.1 World Viral Detection Market Size by Sample Matrix (2021-2026)
7.3.2 World Viral Detection Market Size by Sample Matrix (2027-2032)
7.3.3 World Viral Detection Market Size Market Share by Sample Matrix (2027-2032)
8 MARKET ANALYSIS BY COMPLIANCE LEVEL
8.1 World Viral Detection Market Size Overview by Compliance Level: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Compliance Level
8.2.1 Research Use Only
8.2.2 Non-GLP / Non-GMP Testing
8.2.3 GLP-compliant Testing
8.2.4 GMP-compliant Testing
8.2.5 Regulatory Submission Support Testing
8.2.6 Others
8.3 Market Segment by Compliance Level
8.3.1 World Viral Detection Market Size by Compliance Level (2021-2026)
8.3.2 World Viral Detection Market Size by Compliance Level (2027-2032)
8.3.3 World Viral Detection Market Size Market Share by Compliance Level (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Viral Detection Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Blood & Blood Products
9.2.2 Cellular & Gene Therapy Products
9.2.3 Stem Cell Products
9.2.4 Tissue & Tissue Products
9.2.5 Vaccines and Therapeutics
9.3 Market Segment by Application
9.3.1 World Viral Detection Market Size by Application (2021-2026)
9.3.2 World Viral Detection Market Size by Application (2027-2032)
9.3.3 World Viral Detection Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Merck KGaA
10.1.1 Merck KGaA Details
10.1.2 Merck KGaA Major Business
10.1.3 Merck KGaA Viral Detection Product and Services
10.1.4 Merck KGaA Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Merck KGaA Recent Developments/Updates
10.1.6 Merck KGaA Competitive Strengths & Weaknesses
10.2 Charles River Laboratories
10.2.1 Charles River Laboratories Details
10.2.2 Charles River Laboratories Major Business
10.2.3 Charles River Laboratories Viral Detection Product and Services
10.2.4 Charles River Laboratories Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Charles River Laboratories Recent Developments/Updates
10.2.6 Charles River Laboratories Competitive Strengths & Weaknesses
10.3 Eurofins
10.3.1 Eurofins Details
10.3.2 Eurofins Major Business
10.3.3 Eurofins Viral Detection Product and Services
10.3.4 Eurofins Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Eurofins Recent Developments/Updates
10.3.6 Eurofins Competitive Strengths & Weaknesses
10.4 SGS
10.4.1 SGS Details
10.4.2 SGS Major Business
10.4.3 SGS Viral Detection Product and Services
10.4.4 SGS Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 SGS Recent Developments/Updates
10.4.6 SGS Competitive Strengths & Weaknesses
10.5 Sartorius
10.5.1 Sartorius Details
10.5.2 Sartorius Major Business
10.5.3 Sartorius Viral Detection Product and Services
10.5.4 Sartorius Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Sartorius Recent Developments/Updates
10.5.6 Sartorius Competitive Strengths & Weaknesses
10.6 Asahi Kasei
10.6.1 Asahi Kasei Details
10.6.2 Asahi Kasei Major Business
10.6.3 Asahi Kasei Viral Detection Product and Services
10.6.4 Asahi Kasei Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Asahi Kasei Recent Developments/Updates
10.6.6 Asahi Kasei Competitive Strengths & Weaknesses
10.7 Samsung Biologics
10.7.1 Samsung Biologics Details
10.7.2 Samsung Biologics Major Business
10.7.3 Samsung Biologics Viral Detection Product and Services
10.7.4 Samsung Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 Samsung Biologics Recent Developments/Updates
10.7.6 Samsung Biologics Competitive Strengths & Weaknesses
10.8 Syngene
10.8.1 Syngene Details
10.8.2 Syngene Major Business
10.8.3 Syngene Viral Detection Product and Services
10.8.4 Syngene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Syngene Recent Developments/Updates
10.8.6 Syngene Competitive Strengths & Weaknesses
10.9 Intertek
10.9.1 Intertek Details
10.9.2 Intertek Major Business
10.9.3 Intertek Viral Detection Product and Services
10.9.4 Intertek Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Intertek Recent Developments/Updates
10.9.6 Intertek Competitive Strengths & Weaknesses
10.10 Minaris Advanced Therapies
10.10.1 Minaris Advanced Therapies Details
10.10.2 Minaris Advanced Therapies Major Business
10.10.3 Minaris Advanced Therapies Viral Detection Product and Services
10.10.4 Minaris Advanced Therapies Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 Minaris Advanced Therapies Recent Developments/Updates
10.10.6 Minaris Advanced Therapies Competitive Strengths & Weaknesses
10.11 Texcell
10.11.1 Texcell Details
10.11.2 Texcell Major Business
10.11.3 Texcell Viral Detection Product and Services
10.11.4 Texcell Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 Texcell Recent Developments/Updates
10.11.6 Texcell Competitive Strengths & Weaknesses
10.12 PathoQuest
10.12.1 PathoQuest Details
10.12.2 PathoQuest Major Business
10.12.3 PathoQuest Viral Detection Product and Services
10.12.4 PathoQuest Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 PathoQuest Recent Developments/Updates
10.12.6 PathoQuest Competitive Strengths & Weaknesses
10.13 Clean Cells
10.13.1 Clean Cells Details
10.13.2 Clean Cells Major Business
10.13.3 Clean Cells Viral Detection Product and Services
10.13.4 Clean Cells Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.13.5 Clean Cells Recent Developments/Updates
10.13.6 Clean Cells Competitive Strengths & Weaknesses
10.14 Avance Biosciences
10.14.1 Avance Biosciences Details
10.14.2 Avance Biosciences Major Business
10.14.3 Avance Biosciences Viral Detection Product and Services
10.14.4 Avance Biosciences Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.14.5 Avance Biosciences Recent Developments/Updates
10.14.6 Avance Biosciences Competitive Strengths & Weaknesses
10.15 Microbiologics
10.15.1 Microbiologics Details
10.15.2 Microbiologics Major Business
10.15.3 Microbiologics Viral Detection Product and Services
10.15.4 Microbiologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.15.5 Microbiologics Recent Developments/Updates
10.15.6 Microbiologics Competitive Strengths & Weaknesses
10.16 Alcami
10.16.1 Alcami Details
10.16.2 Alcami Major Business
10.16.3 Alcami Viral Detection Product and Services
10.16.4 Alcami Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.16.5 Alcami Recent Developments/Updates
10.16.6 Alcami Competitive Strengths & Weaknesses
10.17 Creative Biolabs
10.17.1 Creative Biolabs Details
10.17.2 Creative Biolabs Major Business
10.17.3 Creative Biolabs Viral Detection Product and Services
10.17.4 Creative Biolabs Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.17.5 Creative Biolabs Recent Developments/Updates
10.17.6 Creative Biolabs Competitive Strengths & Weaknesses
10.18 Creative Biogene
10.18.1 Creative Biogene Details
10.18.2 Creative Biogene Major Business
10.18.3 Creative Biogene Viral Detection Product and Services
10.18.4 Creative Biogene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.18.5 Creative Biogene Recent Developments/Updates
10.18.6 Creative Biogene Competitive Strengths & Weaknesses
10.19 WuXi AppTec
10.19.1 WuXi AppTec Details
10.19.2 WuXi AppTec Major Business
10.19.3 WuXi AppTec Viral Detection Product and Services
10.19.4 WuXi AppTec Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.19.5 WuXi AppTec Recent Developments/Updates
10.19.6 WuXi AppTec Competitive Strengths & Weaknesses
10.20 WuXi Biologics
10.20.1 WuXi Biologics Details
10.20.2 WuXi Biologics Major Business
10.20.3 WuXi Biologics Viral Detection Product and Services
10.20.4 WuXi Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
10.20.5 WuXi Biologics Recent Developments/Updates
10.20.6 WuXi Biologics Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Viral Detection Industry Chain
11.2 Viral Detection Upstream Analysis
11.3 Viral Detection Midstream Analysis
11.4 Viral Detection Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Viral Detection Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Viral Detection Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Viral Detection Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Viral Detection Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Viral Detection Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Viral Detection Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Viral Detection Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Viral Detection Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Viral Detection Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Viral Detection Players in 2025
Table 12. World Viral Detection Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Viral Detection Company Evaluation Quadrant
Table 14. Head Office of Key Viral Detection Players
Table 15. Viral Detection Market: Company Product Type Footprint
Table 16. Viral Detection Market: Company Product Application Footprint
Table 17. Viral Detection Mergers & Acquisitions Activity
Table 18. United States VS China Viral Detection Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Viral Detection Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Viral Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Viral Detection Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Viral Detection Revenue Market Share (2021-2026)
Table 23. China Based Viral Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Viral Detection Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Viral Detection Revenue Market Share (2021-2026)
Table 26. Rest of World Based Viral Detection Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Viral Detection Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Viral Detection Revenue Market Share (2021-2026)
Table 29. World Viral Detection Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Viral Detection Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Viral Detection Market Size by Type (2027-2032) & (USD Million)
Table 32. World Viral Detection Market Size by Service Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 33. World Viral Detection Market Size Value by Service Delivery Format (2021-2026) & (USD Million)
Table 34. World Viral Detection Market Size by Service Delivery Format (2027-2032) & (USD Million)
Table 35. World Viral Detection Market Size by Sample Matrix, (USD Million), 2021 & 2025 & 2032
Table 36. World Viral Detection Market Size Value by Sample Matrix (2021-2026) & (USD Million)
Table 37. World Viral Detection Market Size by Sample Matrix (2027-2032) & (USD Million)
Table 38. World Viral Detection Market Size by Compliance Level, (USD Million), 2021 & 2025 & 2032
Table 39. World Viral Detection Market Size Value by Compliance Level (2021-2026) & (USD Million)
Table 40. World Viral Detection Market Size by Compliance Level (2027-2032) & (USD Million)
Table 41. World Viral Detection Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World Viral Detection Market Size by Application (2021-2026) & (USD Million)
Table 43. World Viral Detection Market Size by Application (2027-2032) & (USD Million)
Table 44. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 45. Merck KGaA Major Business
Table 46. Merck KGaA Viral Detection Product and Services
Table 47. Merck KGaA Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Merck KGaA Recent Developments/Updates
Table 49. Merck KGaA Competitive Strengths & Weaknesses
Table 50. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 51. Charles River Laboratories Major Business
Table 52. Charles River Laboratories Viral Detection Product and Services
Table 53. Charles River Laboratories Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Charles River Laboratories Recent Developments/Updates
Table 55. Charles River Laboratories Competitive Strengths & Weaknesses
Table 56. Eurofins Basic Information, Manufacturing Base and Competitors
Table 57. Eurofins Major Business
Table 58. Eurofins Viral Detection Product and Services
Table 59. Eurofins Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Eurofins Recent Developments/Updates
Table 61. Eurofins Competitive Strengths & Weaknesses
Table 62. SGS Basic Information, Manufacturing Base and Competitors
Table 63. SGS Major Business
Table 64. SGS Viral Detection Product and Services
Table 65. SGS Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. SGS Recent Developments/Updates
Table 67. SGS Competitive Strengths & Weaknesses
Table 68. Sartorius Basic Information, Manufacturing Base and Competitors
Table 69. Sartorius Major Business
Table 70. Sartorius Viral Detection Product and Services
Table 71. Sartorius Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Sartorius Recent Developments/Updates
Table 73. Sartorius Competitive Strengths & Weaknesses
Table 74. Asahi Kasei Basic Information, Manufacturing Base and Competitors
Table 75. Asahi Kasei Major Business
Table 76. Asahi Kasei Viral Detection Product and Services
Table 77. Asahi Kasei Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Asahi Kasei Recent Developments/Updates
Table 79. Asahi Kasei Competitive Strengths & Weaknesses
Table 80. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 81. Samsung Biologics Major Business
Table 82. Samsung Biologics Viral Detection Product and Services
Table 83. Samsung Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Samsung Biologics Recent Developments/Updates
Table 85. Samsung Biologics Competitive Strengths & Weaknesses
Table 86. Syngene Basic Information, Manufacturing Base and Competitors
Table 87. Syngene Major Business
Table 88. Syngene Viral Detection Product and Services
Table 89. Syngene Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Syngene Recent Developments/Updates
Table 91. Syngene Competitive Strengths & Weaknesses
Table 92. Intertek Basic Information, Manufacturing Base and Competitors
Table 93. Intertek Major Business
Table 94. Intertek Viral Detection Product and Services
Table 95. Intertek Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Intertek Recent Developments/Updates
Table 97. Intertek Competitive Strengths & Weaknesses
Table 98. Minaris Advanced Therapies Basic Information, Manufacturing Base and Competitors
Table 99. Minaris Advanced Therapies Major Business
Table 100. Minaris Advanced Therapies Viral Detection Product and Services
Table 101. Minaris Advanced Therapies Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Minaris Advanced Therapies Recent Developments/Updates
Table 103. Minaris Advanced Therapies Competitive Strengths & Weaknesses
Table 104. Texcell Basic Information, Manufacturing Base and Competitors
Table 105. Texcell Major Business
Table 106. Texcell Viral Detection Product and Services
Table 107. Texcell Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Texcell Recent Developments/Updates
Table 109. Texcell Competitive Strengths & Weaknesses
Table 110. PathoQuest Basic Information, Manufacturing Base and Competitors
Table 111. PathoQuest Major Business
Table 112. PathoQuest Viral Detection Product and Services
Table 113. PathoQuest Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. PathoQuest Recent Developments/Updates
Table 115. PathoQuest Competitive Strengths & Weaknesses
Table 116. Clean Cells Basic Information, Manufacturing Base and Competitors
Table 117. Clean Cells Major Business
Table 118. Clean Cells Viral Detection Product and Services
Table 119. Clean Cells Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Clean Cells Recent Developments/Updates
Table 121. Clean Cells Competitive Strengths & Weaknesses
Table 122. Avance Biosciences Basic Information, Manufacturing Base and Competitors
Table 123. Avance Biosciences Major Business
Table 124. Avance Biosciences Viral Detection Product and Services
Table 125. Avance Biosciences Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Avance Biosciences Recent Developments/Updates
Table 127. Avance Biosciences Competitive Strengths & Weaknesses
Table 128. Microbiologics Basic Information, Manufacturing Base and Competitors
Table 129. Microbiologics Major Business
Table 130. Microbiologics Viral Detection Product and Services
Table 131. Microbiologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Microbiologics Recent Developments/Updates
Table 133. Microbiologics Competitive Strengths & Weaknesses
Table 134. Alcami Basic Information, Manufacturing Base and Competitors
Table 135. Alcami Major Business
Table 136. Alcami Viral Detection Product and Services
Table 137. Alcami Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Alcami Recent Developments/Updates
Table 139. Alcami Competitive Strengths & Weaknesses
Table 140. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 141. Creative Biolabs Major Business
Table 142. Creative Biolabs Viral Detection Product and Services
Table 143. Creative Biolabs Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Creative Biolabs Recent Developments/Updates
Table 145. Creative Biolabs Competitive Strengths & Weaknesses
Table 146. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 147. Creative Biogene Major Business
Table 148. Creative Biogene Viral Detection Product and Services
Table 149. Creative Biogene Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Creative Biogene Recent Developments/Updates
Table 151. Creative Biogene Competitive Strengths & Weaknesses
Table 152. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 153. WuXi AppTec Major Business
Table 154. WuXi AppTec Viral Detection Product and Services
Table 155. WuXi AppTec Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. WuXi AppTec Recent Developments/Updates
Table 157. WuXi AppTec Competitive Strengths & Weaknesses
Table 158. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 159. WuXi Biologics Major Business
Table 160. WuXi Biologics Viral Detection Product and Services
Table 161. WuXi Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. WuXi Biologics Recent Developments/Updates
Table 163. WuXi Biologics Competitive Strengths & Weaknesses
Table 164. Global Key Players of Viral Detection Upstream (Raw Materials)
Table 165. Global Viral Detection Typical Customers
Table 1. World Viral Detection Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Viral Detection Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Viral Detection Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Viral Detection Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Viral Detection Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Viral Detection Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Viral Detection Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Viral Detection Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Viral Detection Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Viral Detection Players in 2025
Table 12. World Viral Detection Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Viral Detection Company Evaluation Quadrant
Table 14. Head Office of Key Viral Detection Players
Table 15. Viral Detection Market: Company Product Type Footprint
Table 16. Viral Detection Market: Company Product Application Footprint
Table 17. Viral Detection Mergers & Acquisitions Activity
Table 18. United States VS China Viral Detection Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Viral Detection Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Viral Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Viral Detection Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Viral Detection Revenue Market Share (2021-2026)
Table 23. China Based Viral Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Viral Detection Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Viral Detection Revenue Market Share (2021-2026)
Table 26. Rest of World Based Viral Detection Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Viral Detection Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Viral Detection Revenue Market Share (2021-2026)
Table 29. World Viral Detection Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Viral Detection Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Viral Detection Market Size by Type (2027-2032) & (USD Million)
Table 32. World Viral Detection Market Size by Service Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 33. World Viral Detection Market Size Value by Service Delivery Format (2021-2026) & (USD Million)
Table 34. World Viral Detection Market Size by Service Delivery Format (2027-2032) & (USD Million)
Table 35. World Viral Detection Market Size by Sample Matrix, (USD Million), 2021 & 2025 & 2032
Table 36. World Viral Detection Market Size Value by Sample Matrix (2021-2026) & (USD Million)
Table 37. World Viral Detection Market Size by Sample Matrix (2027-2032) & (USD Million)
Table 38. World Viral Detection Market Size by Compliance Level, (USD Million), 2021 & 2025 & 2032
Table 39. World Viral Detection Market Size Value by Compliance Level (2021-2026) & (USD Million)
Table 40. World Viral Detection Market Size by Compliance Level (2027-2032) & (USD Million)
Table 41. World Viral Detection Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World Viral Detection Market Size by Application (2021-2026) & (USD Million)
Table 43. World Viral Detection Market Size by Application (2027-2032) & (USD Million)
Table 44. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 45. Merck KGaA Major Business
Table 46. Merck KGaA Viral Detection Product and Services
Table 47. Merck KGaA Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Merck KGaA Recent Developments/Updates
Table 49. Merck KGaA Competitive Strengths & Weaknesses
Table 50. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 51. Charles River Laboratories Major Business
Table 52. Charles River Laboratories Viral Detection Product and Services
Table 53. Charles River Laboratories Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Charles River Laboratories Recent Developments/Updates
Table 55. Charles River Laboratories Competitive Strengths & Weaknesses
Table 56. Eurofins Basic Information, Manufacturing Base and Competitors
Table 57. Eurofins Major Business
Table 58. Eurofins Viral Detection Product and Services
Table 59. Eurofins Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Eurofins Recent Developments/Updates
Table 61. Eurofins Competitive Strengths & Weaknesses
Table 62. SGS Basic Information, Manufacturing Base and Competitors
Table 63. SGS Major Business
Table 64. SGS Viral Detection Product and Services
Table 65. SGS Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. SGS Recent Developments/Updates
Table 67. SGS Competitive Strengths & Weaknesses
Table 68. Sartorius Basic Information, Manufacturing Base and Competitors
Table 69. Sartorius Major Business
Table 70. Sartorius Viral Detection Product and Services
Table 71. Sartorius Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Sartorius Recent Developments/Updates
Table 73. Sartorius Competitive Strengths & Weaknesses
Table 74. Asahi Kasei Basic Information, Manufacturing Base and Competitors
Table 75. Asahi Kasei Major Business
Table 76. Asahi Kasei Viral Detection Product and Services
Table 77. Asahi Kasei Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Asahi Kasei Recent Developments/Updates
Table 79. Asahi Kasei Competitive Strengths & Weaknesses
Table 80. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 81. Samsung Biologics Major Business
Table 82. Samsung Biologics Viral Detection Product and Services
Table 83. Samsung Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Samsung Biologics Recent Developments/Updates
Table 85. Samsung Biologics Competitive Strengths & Weaknesses
Table 86. Syngene Basic Information, Manufacturing Base and Competitors
Table 87. Syngene Major Business
Table 88. Syngene Viral Detection Product and Services
Table 89. Syngene Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Syngene Recent Developments/Updates
Table 91. Syngene Competitive Strengths & Weaknesses
Table 92. Intertek Basic Information, Manufacturing Base and Competitors
Table 93. Intertek Major Business
Table 94. Intertek Viral Detection Product and Services
Table 95. Intertek Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Intertek Recent Developments/Updates
Table 97. Intertek Competitive Strengths & Weaknesses
Table 98. Minaris Advanced Therapies Basic Information, Manufacturing Base and Competitors
Table 99. Minaris Advanced Therapies Major Business
Table 100. Minaris Advanced Therapies Viral Detection Product and Services
Table 101. Minaris Advanced Therapies Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Minaris Advanced Therapies Recent Developments/Updates
Table 103. Minaris Advanced Therapies Competitive Strengths & Weaknesses
Table 104. Texcell Basic Information, Manufacturing Base and Competitors
Table 105. Texcell Major Business
Table 106. Texcell Viral Detection Product and Services
Table 107. Texcell Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Texcell Recent Developments/Updates
Table 109. Texcell Competitive Strengths & Weaknesses
Table 110. PathoQuest Basic Information, Manufacturing Base and Competitors
Table 111. PathoQuest Major Business
Table 112. PathoQuest Viral Detection Product and Services
Table 113. PathoQuest Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. PathoQuest Recent Developments/Updates
Table 115. PathoQuest Competitive Strengths & Weaknesses
Table 116. Clean Cells Basic Information, Manufacturing Base and Competitors
Table 117. Clean Cells Major Business
Table 118. Clean Cells Viral Detection Product and Services
Table 119. Clean Cells Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Clean Cells Recent Developments/Updates
Table 121. Clean Cells Competitive Strengths & Weaknesses
Table 122. Avance Biosciences Basic Information, Manufacturing Base and Competitors
Table 123. Avance Biosciences Major Business
Table 124. Avance Biosciences Viral Detection Product and Services
Table 125. Avance Biosciences Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Avance Biosciences Recent Developments/Updates
Table 127. Avance Biosciences Competitive Strengths & Weaknesses
Table 128. Microbiologics Basic Information, Manufacturing Base and Competitors
Table 129. Microbiologics Major Business
Table 130. Microbiologics Viral Detection Product and Services
Table 131. Microbiologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Microbiologics Recent Developments/Updates
Table 133. Microbiologics Competitive Strengths & Weaknesses
Table 134. Alcami Basic Information, Manufacturing Base and Competitors
Table 135. Alcami Major Business
Table 136. Alcami Viral Detection Product and Services
Table 137. Alcami Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Alcami Recent Developments/Updates
Table 139. Alcami Competitive Strengths & Weaknesses
Table 140. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 141. Creative Biolabs Major Business
Table 142. Creative Biolabs Viral Detection Product and Services
Table 143. Creative Biolabs Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Creative Biolabs Recent Developments/Updates
Table 145. Creative Biolabs Competitive Strengths & Weaknesses
Table 146. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 147. Creative Biogene Major Business
Table 148. Creative Biogene Viral Detection Product and Services
Table 149. Creative Biogene Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Creative Biogene Recent Developments/Updates
Table 151. Creative Biogene Competitive Strengths & Weaknesses
Table 152. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 153. WuXi AppTec Major Business
Table 154. WuXi AppTec Viral Detection Product and Services
Table 155. WuXi AppTec Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. WuXi AppTec Recent Developments/Updates
Table 157. WuXi AppTec Competitive Strengths & Weaknesses
Table 158. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 159. WuXi Biologics Major Business
Table 160. WuXi Biologics Viral Detection Product and Services
Table 161. WuXi Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. WuXi Biologics Recent Developments/Updates
Table 163. WuXi Biologics Competitive Strengths & Weaknesses
Table 164. Global Key Players of Viral Detection Upstream (Raw Materials)
Table 165. Global Viral Detection Typical Customers
LIST OF FIGURES
Figure 1. Viral Detection Picture
Figure 2. World Viral Detection Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Viral Detection Total Revenue (2021-2032) & (USD Million)
Figure 4. World Viral Detection Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Viral Detection Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 13. Viral Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 16. World Viral Detection Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 18. China Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 23. India Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Viral Detection by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Viral Detection Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Viral Detection Markets in 2025
Figure 27. United States VS China: Viral Detection Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Viral Detection Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Viral Detection Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Viral Detection Market Size Market Share by Type in 2025
Figure 31. Plaque Assays
Figure 32. PCR
Figure 33. ELISA
Figure 34. Others
Figure 35. World Viral Detection Market Size Market Share by Type (2021-2032)
Figure 36. World Viral Detection Market Size by Service Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 37. World Viral Detection Market Size Market Share by Service Delivery Format in 2025
Figure 38. Standard Testing Services
Figure 39. Customized Method Development Services
Figure 40. Validation Services
Figure 41. Batch Release Testing Services
Figure 42. Investigation Services
Figure 43. Others
Figure 44. World Viral Detection Market Size Market Share by Service Delivery Format (2021-2032)
Figure 45. World Viral Detection Market Size by Sample Matrix, (USD Million), 2021 & 2025 & 2032
Figure 46. World Viral Detection Market Size Market Share by Sample Matrix in 2025
Figure 47. Raw Materials
Figure 48. Cell Banks
Figure 49. Viral Seed Stocks / Viral Vectors
Figure 50. In-Process Samples
Figure 51. Bulk Harvest / Drug Substance
Figure 52. Final Product
Figure 53. Others
Figure 54. Others
Figure 55. World Viral Detection Market Size Market Share by Sample Matrix (2021-2032)
Figure 56. World Viral Detection Market Size by Compliance Level, (USD Million), 2021 & 2025 & 2032
Figure 57. World Viral Detection Market Size Market Share by Compliance Level in 2025
Figure 58. Research Use Only
Figure 59. Non-GLP / Non-GMP Testing
Figure 60. GLP-compliant Testing
Figure 61. GMP-compliant Testing
Figure 62. Regulatory Submission Support Testing
Figure 63. Others
Figure 64. World Viral Detection Market Size Market Share by Compliance Level (2021-2032)
Figure 65. World Viral Detection Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 66. World Viral Detection Market Size Market Share by Application in 2025
Figure 67. Blood & Blood Products
Figure 68. Cellular & Gene Therapy Products
Figure 69. Stem Cell Products
Figure 70. Tissue & Tissue Products
Figure 71. Vaccines and Therapeutics
Figure 72. World Viral Detection Market Size Market Share by Application (2021-2032)
Figure 73. Viral Detection Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Viral Detection Picture
Figure 2. World Viral Detection Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Viral Detection Total Revenue (2021-2032) & (USD Million)
Figure 4. World Viral Detection Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Viral Detection Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Viral Detection Revenue (2021-2032) & (USD Million)
Figure 13. Viral Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 16. World Viral Detection Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 18. China Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 23. India Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Viral Detection by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Viral Detection Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Viral Detection Markets in 2025
Figure 27. United States VS China: Viral Detection Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Viral Detection Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Viral Detection Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Viral Detection Market Size Market Share by Type in 2025
Figure 31. Plaque Assays
Figure 32. PCR
Figure 33. ELISA
Figure 34. Others
Figure 35. World Viral Detection Market Size Market Share by Type (2021-2032)
Figure 36. World Viral Detection Market Size by Service Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 37. World Viral Detection Market Size Market Share by Service Delivery Format in 2025
Figure 38. Standard Testing Services
Figure 39. Customized Method Development Services
Figure 40. Validation Services
Figure 41. Batch Release Testing Services
Figure 42. Investigation Services
Figure 43. Others
Figure 44. World Viral Detection Market Size Market Share by Service Delivery Format (2021-2032)
Figure 45. World Viral Detection Market Size by Sample Matrix, (USD Million), 2021 & 2025 & 2032
Figure 46. World Viral Detection Market Size Market Share by Sample Matrix in 2025
Figure 47. Raw Materials
Figure 48. Cell Banks
Figure 49. Viral Seed Stocks / Viral Vectors
Figure 50. In-Process Samples
Figure 51. Bulk Harvest / Drug Substance
Figure 52. Final Product
Figure 53. Others
Figure 54. Others
Figure 55. World Viral Detection Market Size Market Share by Sample Matrix (2021-2032)
Figure 56. World Viral Detection Market Size by Compliance Level, (USD Million), 2021 & 2025 & 2032
Figure 57. World Viral Detection Market Size Market Share by Compliance Level in 2025
Figure 58. Research Use Only
Figure 59. Non-GLP / Non-GMP Testing
Figure 60. GLP-compliant Testing
Figure 61. GMP-compliant Testing
Figure 62. Regulatory Submission Support Testing
Figure 63. Others
Figure 64. World Viral Detection Market Size Market Share by Compliance Level (2021-2032)
Figure 65. World Viral Detection Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 66. World Viral Detection Market Size Market Share by Application in 2025
Figure 67. Blood & Blood Products
Figure 68. Cellular & Gene Therapy Products
Figure 69. Stem Cell Products
Figure 70. Tissue & Tissue Products
Figure 71. Vaccines and Therapeutics
Figure 72. World Viral Detection Market Size Market Share by Application (2021-2032)
Figure 73. Viral Detection Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
